Retrospective Observational Study on Telemedicine in Sublingual Immunotherapy for Patients with Japanese Cedar Pollinosis and House Dust Mite Allergic Rhinitis-Reference-Cited by-同舟云学术

Retrospective Observational Study on Telemedicine in Sublingual Immunotherapy for Patients with Japanese Cedar Pollinosis and House Dust Mite Allergic Rhinitis

Published:2024-09-11 Issue: Volume: Page:
ISSN:1530-5627
Container-title:Telemedicine and e-Health
language:en
Short-container-title:Telemedicine and e-Health

Author:

Inoo Yumi¹²^ORCID,Iida Hiroshi¹,Nakada Hiroto³,Tezuka Katsuhiko⁴,Kikuchi Yasutake⁵,Fujimura Eiichi⁶,Nishikawa Tasuku⁷,Yamamoto Kazuhiro⁸,Ida Yutaro⁹,Saigusa Yusuke¹⁰,Hatano Takashi¹¹,Inamori Masahiko¹^ORCID

Affiliation:

1. Department of Medical Education, Yokohama City University School of Medicine, Kanagawa, Japan.

2. Medley, Inc., Tokyo, Japan.

3. Holon Toriizaka Clinic, Tokyo, Japan.

4. The Medical Corporations of Sawakou-kai Tezuka Otorhinolaryngology, Kanagawa, Japan.

5. The Medical Corporations of Seizin-kai Kikuchi Otorhinolaryngology, Miyazaki, Japan.

6. The Medical Corporations Fujimura Otorhinolaryngology Clinic, Hyogo, Japan.

7. The Medical Corporations of Nishikawa Nishikawa Otorhinolaryngology, Osaka, Japan.

8. Yamamoto Otorhinolaryngology, Tokyo, Japan.

9. Kamata Ida Otorhinolaryngology, Tokyo, Japan.

10. Department of Biostatistics, Yokohama City University School of Medicine, Kanagawa, Japan.

11. Department of Otorhinolaryngology, Head & Neck Surgery, Yokohama City University School of Medicine, Kanagawa, Japan.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/tmj.2024.0065

Reference21 articles.

1. Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status

2. Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet

3. Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens

4. Immunotherapy compliance: comparison of subcutaneous versus sublingual immunotherapy